@article{5512ccd104da4872bf861e602f9ef543,
title = "Triple therapy (ICS/LABA/LAMA) in COPD: time for a reappraisal",
keywords = "muscarinic antagonists, adrenergic beta(2) receptor agonists, glucocorticoids, pulmonary disease, chronic obstructive, review, exacerbations, safety, OBSTRUCTIVE PULMONARY-DISEASE, DOUBLE-BLIND, INHALED CORTICOSTEROIDS, FLUTICASONE PROPIONATE/SALMETEROL, PARALLEL-GROUP, BRONCHODILATOR THERAPY, CARDIOVASCULAR EVENTS, AIRWAY INFLAMMATION, BETA-AGONISTS, TIOTROPIUM",
author = "Lowie Vanfleteren and Fabbri, {Leonardo M.} and Alberto Papi and Stefano Petruzzelli and Bartolome Celli",
year = "2018",
month = jan,
day = "1",
doi = "10.2147/COPD.S185975",
language = "English",
volume = "13",
pages = "3971--3981",
journal = "International journal of chronic obstructive pulmonary disease",
issn = "1178-2005",
publisher = "Dove Medical Press Ltd",
}